Abbott pumps $450M+ into new Ireland-based manufacturing site project and hiring spree
As Ireland continues to see more investments and building projects from pharma companies, another contender is looking to place more investment in the Emerald Isle.
According to a report from The Irish Times on Friday, Abbott Laboratories is investing €440 million, or about $451 million, to build a new manufacturing plant in Kilkenny, located in the country’s southeast, to make more of its glucose monitors.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.